Sana Biotechnology, Inc. SANA
2.43 USD -0.03 (-1.42%)
At closeNov 11, 2026, 6:02 AM EST
2.40 -0.03 -1.23%
Pre-market · Nov 11, 6:02 AM ET
2.32 Day range 2.52
2.22 52-week range 5.49
- YTD
- -40.29%
- 1 year
- -42.69%
Held by funds
78 US ETFs and mutual funds hold SANA · largest positions
Ownership
Held by insiders 6.08%
Held by institutions 77.61%
Float held by institutions 82.64%
Institutions 274
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 12.50% | 37,429,515 | 129.13M | Jun 29, 2026 |
| Flagship Pioneering LLC | 8.35% | 25,001,856 | 86.26M | Jun 29, 2026 |
| RA Capital Management, L.P. | 6.26% | 18,750,000 | 64.69M | Jun 29, 2026 |
| Blackrock Inc. | 5.57% | 16,675,173 | 57.53M | Jun 29, 2026 |
| State Street Corporation | 3.74% | 11,203,134 | 38.65M | Jun 29, 2026 |
| Canada Pension Plan Investment Board | 3.41% | 10,218,400 | 35.25M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 3.51% | 10,495,617 | 36.21M | Jul 30, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.36% | 7,077,517 | 24.42M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.09% | 6,251,644 | 21.57M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.61% | 4,807,959 | 16.59M | Jun 29, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 1.04% | 3,119,059 | 10.76M | Jul 30, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 0.95% | 2,857,700 | 9.86M | Jul 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BISHOP HANS EDGAR | Director | Stock Award(Grant) | Jul 5, 2026 | 5,854,800 |
| CASSIDY BERNARD J | General Counsel | Conversion of Exercise of derivative security | Mar 6, 2025 | 112,990 |
| FMR LLC | Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 7, 2025 | 0 |
| HARR STEVE M.D. | Chief Executive Officer | Conversion of Exercise of derivative security | Mar 5, 2026 | 8,960,750 |
| MULLIGAN RICHARD CHARLES PH.D | Director | Sale | Sep 24, 2024 | 2,698,120 |
| WYRICK SUSAN D | Officer | Conversion of Exercise of derivative security | Mar 5, 2026 | 196,196 |